L. Guanchiale

Hospital Privado — Argentina

Medicine · Health Sciences

1h-index1citations11works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(6), Chronic Lymphocytic Leukemia Research(3), Acute Myeloid Leukemia Research(2), Lung Cancer Treatments and Mutations(1), Cancer, Hypoxia, and Metabolism(1)

Publications11 total

826 | PET‐CT–ADAPTED TREATMENT FOR EARLY‐STAGE DIFFUSE LARGE B‐CELL LYMPHOMA WITHOUT RISK FACTORS: PRELIMINARY ANALYSIS FROM THE GATLA GROUP
Hematological Oncology·2025Open Access
363 | REAL‐WORLD EVIDENCE OF BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS TRANSPLANT IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA: 2‐YEAR FOLLOW‐UP FROM THE GATLA STUDY
Hematological Oncology·2025Open Access
649 | RESPONSES, OVERAL SURVIVAL AND TOXICITY IN ADULT PATIENTS WITH BURKITT LYMPHOMA TREATED WITH THE BURKIMAB‐13 PROTOCOL DATA OF TWO INSTITUTIONS IN ARGENTINA
Hematological Oncology·2025Open Access
Leucemia/linfoma agudo de linaje mixto no leucémico en paciente pediátrico
Revista Hematología·2024Open Access
EPIDEMIOLOGY, CLINICAL FEATURES AND OUTCOMES OF PERIPHERAL T-CELL LYMPHOMA IN LATIN AMERICA
Hematology Transfusion and Cell Therapy·2023Open Access
PROSPECTIVE REAL WORLD EVIDENCE: USE OF BRENTUXIMAB VEDOTIN AS CONSOLIDATION THERAPY AFTER AUTOLOGOUS TRANSPLANT IN HODGKIN LYMPHOMA. AN INTERIM ANALYSIS, ON BEHALF OF GATLA
Hematological Oncology·2023Open Access
PB1865: SINGLE-COUNTRY, MULTICENTER, RETROSPECTIVE, OBSERVATIONAL, DESCRIPTIVE COHORT STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH VENETOCLAX IN ARGENTINA (VENARG).
HemaSphere·2022· 1 citedOpen Access
PET‐ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG TERM FOLLOW UP OF THE GATLA LH‐05 TRIAL
Hematological Oncology·2021Open Access
Pequeñas moléculas para el tratamiento de la LLC. Inhibidores de la BTK de segunda generación: acalabrutinib
Dialnet (Universidad de la Rioja)·2018
Brentuximab vedotin: A retrospective multicenter analysis of its indication, safety and efficacy in Argentina
Hematological Oncology·2017Open Access
Trasplante alogénico de células progenitoras hematopoyéticas en pacientes con mielofibrosis: resultados del Grupo Argentino de Trasplante de Médula Ósea (GATMO)
Dialnet (Universidad de la Rioja)·2017

Frequent Co-authors

Lorena Fiad(6), Fernando Warley(5), A J Pavlovsky(4), Ana Lisa Basquiera(3), A. Cerutti(3), Luciano Salvano(3), F. Negri Aranguren(3), J L Altuve(3), Laura Korin(3), Guillermina Remaggi(2), Alicia Enrico(2), Maximiliano Riddick(2), Amalia Cerutti(2), Sol Jarchum(2), María Orlova(2), Gonzalo Bentolila(2), M. Castro(2), Soledad Cruset(2), Carolina Mahuad(2), R. Mariano(2)